Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 2,092 shares at $45.69 ($95,583)
  4. 4 Open-market sale EVP, Strategy & Innovation sold 7,137 shares at an average $46.28 ($330,290)
  5. 4 Open-market sale Director sold 13,000 shares at an average $46.28 ($601,615)
  6. 4 Other disposition EVP, Strategy & Innovation disposed of 8,398 shares (other)
  7. 4 Option exercise Director acquired 4,320 shares (option exercise)
  8. 4/A Open-market sale Director sold 7,598 shares at $41.05 ($311,898)
  9. 4 Open-market sale Director sold 18,978 shares at an average $39.99 ($758,983)
  10. 4 Open-market sale Director sold 25,000 shares at $38.70 ($967,500)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 19 · 370 filings